Adhesion and colonization are prerequisites for the establishment of bacterial pathogenesis. The prevention of adhesion is an attractive target for the development of new therapies in the prevention of infection. Bacteria have developed a multiplicity of adhesion mechanisms commonly targeting surface carbohydrate structures, but our ability to rationally design effective antiadhesives is critically affected by the limitations of our knowledge of the human ‘glycome’ and of the bacterial function in relation to it. The potential for the future development of carbohydrate-based antiadhesives has been demonstrated by a significant number of in vitro and in vivo studies. Such therapies will be particularly relevant for infections of mucosal surfaces where topical application or delivery is possible.

1.
Overbye KM, Barrett JF: Antibiotics: where did we go wrong? Drug Discov Today 2005;10:45–52.
2.
Roberts MC: Antibiotic resistance mechanisms in bacteria of oral and upper respiratory origin. Int J Antimicrob Agents 1998;9:255–267.
3.
Fux CA, Costerton JW, Stewart PS, Stoodley P: Survival strategies of infectious biofilms. Trends Microbiol 2005;13:34–40.
4.
Morton LHG, Greenway DLA, Gaylarde CC, Surman SB: Consideration of some implications of the resistance of biofilms to biocides. Int Biodeterioration Biodegrad 1998;41:247–259.
5.
Cazzola M, Matera MG, Pezzuto G: Inflammation – A new therapeutic target in pneumonia. Respiration 2005;72:117–126.
6.
Wahl M: Marine epiobiosis. 1. Fouling and antifouling: some basic aspects. Marine Ecol Prog Ser 1989;58:175–189.
7.
Kelly CG, Younson JS: Anti-adhesive strategies in the prevention of infectious disease at mucosal surfaces. Expert Opin Investig Drugs 2000;9:1711–1721.
8.
Bavington CD, Lever R, Mulloy B, Grundy MM, Page CP, Richardson NV, McKenzie JD: Anti-adhesive glycoproteins in echinoderm mucus secretions. Comp Biochem Physiol B Biochem Mol Biol 2004;139:607–617.
9.
Rose MC: Mucins: structure, function, and role in pulmonary diseases. Am J Physiol 1992;263:L413–L429.
10.
Carlstedt I, Davies JR: Glycoconjugates facing the outside world. Biochem Soc Trans 1997;25:214–219.
11.
Clare AS: Marine natural product antifoulants: status and potential. Biofouling 1995;9:211–229.
12.
Suzuki Y, Tasumi S, Tsutsui S, Okamoto M, Suetake H: Molecular diversity of skin mucus lectins in fish. Comp Biochem Physiol B Biochem Mol Biol 2003;136:723–730.
13.
Callow ME, Fletcher RL: The influence of low surface energy materials on bioadhesion – A review. Int Biodeterioration Biodegrad 1994;1994:333–348.
14.
Hermansson M: The DLVO theory in microbial adhesion. Colloids Surf B Biointerfaces 1999;14:105–119.
15.
Eick S, Glockmann E, Brandl B, Pfister W: Adherence of Streptococcus mutans to various restorative materials in a continuous flow system. J Oral Rehabil 2004;31:278–285.
16.
Walker SL, Redman JA, Elimelech M: Role of LPS composition on bacterial adhesion and detachment under flow conditions. Abstr Pap Am Chem Soc, New Orleans, 2003, vol 225, p 60.
17.
Zheng D, Taylor GT, Gyananath G: Influence of laminar flow velocity and nutrient concentration on attachment of marine bacterioplankton. Biofouling 1994;8:107–120.
18.
Fletcher M: Bacterial attachment in aquatic environments: a diversity of surfaces and adhesion strategies; in Fletcher M (ed): Bacterial Adhesion: Molecular and Ecological Diversity, ed 1. New York, Wiley-Liss, 1996, pp 1–24.
19.
Bryers JD: Bacterial biofilms. Curr Opin Biotechnol 1993;4:197–204.
20.
Costerton JW, Geesey GG, Cheng KJ: How bacteria stick. Sci Am 1978;238:86–95.
21.
Perez-Vilar J, Hill R: The structure and assembly of secreted mucins. J Biol Chem 1999;277:31751–31754.
22.
Sandberg T, Nestor M, Pahlson C, Shi L, Caldwell KD: Mucin as surface protectant against bacterial adhesion. Abstr Pap Am Chem Soc, 2000, vol 220, pp 35–COLL.
23.
Carraway KL, Fregien N: Mucin structure and function: insights from molecular biology. Trends Glycosci Glycotechnol 1995;7:31–44.
24.
Van Klinken BJW, Dekker J, Buller HA, Einerhand AWC: Mucin gene structure and expression: protection vs. adhesion. Am J Physiol 1995;269:G613–G627.
25.
Carnoy C, Ramphal R, Scharfman A, Loguidice JM, Houdret N, Klein A, Galabert C, Lamblin G, Roussel P: Altered carbohydrate composition of salivary mucins from patients with cystic fibrosis and the adhesion of Pseudomonas aeruginosa. Am J Respir Cell Mol Biol 1993;9:323–334.
26.
Niemann HH, Schubert WD, Heinz DW: Adhesins and invasins of pathogenic bacteria: a structural view. Microbes Infect 2004;6:101–112.
27.
Oelschlaeger TA: Adhesins as invasins. Int J Med Microbiol 2001;291:7–14.
28.
Goldstein IJ, Hayes CE: The lectins: carbohydrate binding proteins of plants and animals. Adv Carbohydr Chem Biochem 1978;35:127–340.
29.
Arason GJ: Lectins as defence molecules in vertebrates and invertebrates. Fish Shellfish Immunol 1996;6:277–289.
30.
Beuth J, Ko HL, Pulverer G, Uhlenbruck G, Pichlmaier H: Importance of lectins for the prevention of bacterial infections and cancer metastases. Glycoconj J 1995;12:1–6.
31.
Kawabata SI, Iwanaga S: Role of lectins in the innate immunity of horseshoe crab. Dev Comp Immunol 1999;23:391–400.
32.
Sano H, Kuroki Y: The lung collectins, SP-A and SP-D, modulate pulmonary innate immunity. Mol Immunol 2005;42:279–287.
33.
Wright RK, Cooper EL: Protochordate immunity. 2. Diverse hemolymph lectins in the solitary tunicate Styela clava. Comp Biochem Physiol B Biochem Mol Biol 1984;79:269–277.
34.
Patti JM, Hook M: Microbial adhesins recognizing extracellular matrix macromolecules. Curr Opin Cell Biol 1994;6:752–758.
35.
Lee SY, Yin Z, Ge R, Sin YM: Isolation and characterization of fish Aeromonas hydrophila adhesins important for in vitro epithelial cell invasion. J Fish Dis 1997;20:169–175.
36.
Merino S, Rubires X, Aguilar A, Tomas JM: The role of flagella and motility in the adherence and invasion to fish cell lines by Aeromonas hydrophila serogroup O:34 strains. FEMS Microbiol Lett 1997;151:213–217.
37.
Yilmaz O, Watanabe K, Lamont RJ: Involvement of integrins in fimbriae-mediated binding and invasion by Porphyromonas gingivalis. Cell Microbiol 2002;4:305–314.
38.
Azghani AO, Idell S, Bains M, Hancock REW: Pseudomonas aeruginosa outer membrane protein F is an adhesin in bacterial binding to lung epithelial cells in culture. Microb Pathog 2002;33:109–114.
39.
Carnoy C, Scharfman A, Van Brussel E, Lamblin G, Ramphal R, Roussel P: Pseudomonas aeruginosa outer membrane adhesins for human respiratory mucus glycoproteins. Infect Immun 1994;62:1896–1900.
40.
Doig P, Todd T, Sastry PA, Lee KK, Hodges RS, Paranchych W, Irvin RT: Role of pili in adhesion of Pseudomonas aeruginosa to human respiratory epithelial cells. Infect Immu 1988;56:1641–1646.
41.
Saiman L, Prince A: Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. J Clin Invest 1993;92:1875–1880.
42.
Tang H, Kays M, Prince A: Role of Pseudomonas aeruginosa pili in acute pulmonary infection. Infect Immu 1995;63:1278–1285.
43.
Buts L, Bouckaert J, De Genst E, Loris R, Oscarson S, Lahmann M, Messens J, Brosens E, Wyns L, De Greve H: The fimbrial adhesin F17-G of enterotoxigenic Escherichia coli has an immunoglobulin-like lectin domain that binds N-acetylglucosamine. Mol Microbiol 2003;49:705–715.
44.
Ramphal R, Arora SK, Ritchings BW: Recognition of mucin by the adhesin-flagellar system of Pseudomonas aeruginosa. Am J Respir Crit Care Med 1996;154:S170–S174.
45.
Smyth CJ, Marron MB, Twohig JMGJ, Smith SGJ: Fimbrial adhesins: similarities and variations in structure and biogenesis. FEMS Immunol Med Microbiol 1996;16:127–139.
46.
Lee KK, Sheth HB, Wong WY, Sherburne R, Paranchych W, Hodges RS, Lingwood CA, Krivan H, Irvin RT: The binding of Pseudomonas aeruginosa pili to glycosphingolipids is a tip-associated event involving the C-terminal region of the structural pilin subunit. Mol Microbiol 1994;11:705–713.
47.
Cundell DR, Tuomanen EI: Receptor specificity of adherence of Streptococcus pneumoniae to human type-II pneumocytes and vascular endothelial cells in vitro. Microb Pathog 1994;17:361–374.
48.
Schulenberg B, Beechem JM, Patton WF: Mapping glycosylation changes related to cancer using the Multiplexed Proteomics technology: a protein differential display approach. J Chromatogr B Analyt Technol Biomed Life Sci 2003;793:127–139.
49.
Cacalano G, Kays M, Saiman L, Prince A: Production of the Pseudomonasaeruginosa neuraminidase is increased under hyperosmolar conditions and is regulated by genes involved in alginate expression. J Clin Invest 1992;89:1866–1874.
50.
Tong HH, Liu X, Chen YP, James M, DeMaria T: Effect of neuraminidase on receptor-mediated adherence of Streptococcus pneumoniae to chinchilla tracheal epithelium. Acta Otolaryngol 2002;122:413–419.
51.
Tong HH, McIver MA, Fisher LM, DeMaria TF: Effect of lacto-N-neotetraose, asialoganglioside-GM1 and neuraminidase on adherence of otitis media-associated serotypes of Streptococcus pneumoniae to chinchilla tracheal epithelium. Microb Pathog 1999;26:111–119.
52.
Peltola VT, McCullers JA: Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr Infect Dis J 2004;23:S87–S96.
53.
Abu-Lail NI, Camesano TA: Role of lipopolysaccharides in the adhesion, retention, and transport of Escherichia coli JM109. Environ Sci Technol 2003;37:2173–2183.
54.
Spillmann D, Burger MM: Carbohydrate-carbohydrate interactions in adhesion. J Cell Biochem 1996;61:562–568.
55.
Makihira S, Nikawa H, Tamagami M, Hamada T, Nishimura H, Ishida K, Yamashiro H: Bacterial and candida adhesion to intact and denatured collagen in vitro. Mycoses 2002;45:389–392.
56.
Isberg RR, Leong JM: Multiple [beta]1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell 1990;60:861–871.
57.
Wong KW, Isberg RR: Emerging views on integrin signaling via Rac1 during invasin-promoted bacterial uptake. Curr Opin Microbiol 2005;8:4–9.
58.
Chhatwal GS: Anchorless adhesins and invasins of Gram-positive bacteria: a new class of virulence factors. Trends Microbiol 2002;10:205–208.
59.
Simon PM, Goode PL, Mobasseri A, Zopf D: Inhibition of Helicobacter pylori binding to gastrointestinal epithelial cells by sialic acid-containing oligosaccharides. Infect Immun 1996;65:750–757.
60.
Pieters RJ: Interference with lectin binding and bacterial adhesion by multivalent carbohydrates and peptidic carbohydrate mimics. Trends Glycosci Glycotechnol 2004;16:243–254.
61.
von Specht BU, Knapp B, Hungerer KD, Lucking C, Schmitt A, Domdey H: Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates. J Biotechnol 1996;44:145–153.
62.
Bouckaert J, Berglund J, Schembri M, De Genst E, Cools L, Wuhrer M, Hung CS, Pinkner J, Slattegard R, Zavialov A, Choudhury D, Langermann S, Hultgren SJ, Wyns L, Klemm P, Oscarson S, Knight SD, De Greve H: Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin. Mol Microbiol 2005;55:441–455.
63.
Langermann S, Ballou WR: Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections. J Infect Dis 2001;183:S84–S86.
64.
Langermann S, Mollby R, Burlein JE, Palaszynski SR, Auguste CG, DeFusco A, Strouse R, Schenerman MA, Hultgren SJ, Pinkner JS, Winberg J, Guldevall L, Soderhall M, Ishikawa K, Normark S, Koenig S: Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J Infect Dis 2000;181:774–778.
65.
Meiland R, Geerlings SE, Langermann S, Brouwer EC, Coenjaerts FEJ, Hoepelman AIM: FimCH antiserum inhibits the adherence of Escherichia coli to cells collected by voided urine specimens of diabetic women. J Urol 2004;171:1589–1593.
66.
Doig P, Sastry PA, Hodges RS, Lee KK, Paranchych W, Irvin RT: Inhibition of pilus-mediated adhesion of Pseudomonas aeruginosa to human buccal epithelial cells by monoclonal antibodies directed against pili. Infect Immun 1990;58:124–130.
67.
Guzman-Murillo MA, Ruiz-Bustos E, Ho B, Ascencio F: Involvement of the heparan sulphate-binding proteins of Helicobacter pylori in its adherence to HeLa S3 and Kato III cell lines. J Med Microbiol 2001;50:320–329.
68.
Piatti G: Bacterial adhesion to respiratory mucosa and its modulation by antibiotics at sub-inhibitory concentrations. Pharmacol Res 1994;30:289–299.
69.
Patel A, Lindhorst TK: Synthesis of ‘mixed type’ oligosaccharide mimetics based on a carbohydrate scaffold. Eur J Org Chem 2002:79–86.
70.
Avci FY, Karst NA, Linhardt RJ: Synthetic oligosaccharides as heparin-mimetics displaying anticoagulant properties. Curr Pharm Des 2003;9:2323–2335.
71.
Petitou M: From heparin to synthetic oligosaccharides. Bull Acad Natl Med 2003;187:47–56.
72.
Ratner DM, Adams EW, Su J, O’Keefe BR, Mrksich M, Seeberger PH: Probing protein-carbohydrate interactions with microarrays of synthetic oligosaccharides. Chembiochem 2004;5:379–382.
73.
Lever R, Page CR: Novel drug development opportunities for heparin. Nat Rev Drug Dis 2002;1:140–148.
74.
Cazzola M, Saltini C: Novel approaches to treatment of bacterial lower respiratory tract infections: introduction. Respiration 2005;72:7–8.
75.
Shephard KL: Functions for fish mucus. Rev Fish Biol Fish 1994;4:401–429.
76.
Tromeur F, Guerard F, Le Gal Y: Mucous glycoproteins from the ray Raja batis. Comp Biochem Physiol 1992;102B:773–778.
77.
Meikle P, Richards GN, Yellowlees D: Structural determination of the oligosaccharide side chains from a glycoprotein isolated from the mucus of the coral Acropora formosa. J Biol Chem 1987;262:16941–16947.
78.
Canicatti C: Evolution of the lytic system in echinoderms. 2. Naturally occurring hemolytic activity in Marthasterias glacialis (Asteroidea) coelomic fluid. Comp Biochem Physiol 1989;93A:587–591.
79.
Canicatti C, D’Ancona G: Biological protective substances in Marthasterias glacialis (Asteroidea) epidermal secretion. J Zool 1990;222:445–454.
80.
Ebran N, Julien S, Orange N, Auperin B, Molle G: Isolation and characterization of novel glycoproteins from fish epidermal mucus: correlation between their pore-forming properties and their antibacterial activities. Biochim Biophys Acta 2000;1467:271–280.
81.
Ebran N, Julien S, Orange N, Saglio P, Lemaitre C, Molle G: Pore-forming properties and antibacterial activity of proteins extracted from epidermal mucus of fish. Comp Biochem Physiol A Mol Integr Physiol 1999;122:181–189.
82.
Smith VJ, Fernandes JM, Jones SJ, Kemp GD, Tatner MF: Antibacterial proteins in rainbow trout, Oncorhynchus mykiss. Fish Shellfish Immunol 2000;10:243–260.
83.
Belarbi E, Gomez AC, Chisti Y, Camacho FG, Grima EM: Producing drugs from marine sponges. Biotechnol Adv 2003;21:585–598.
84.
Li HY, Matsunaga S, Fusetani N: Antifungal metabolites from marine sponges. Curr Org Chem 1998;2:649–682.
85.
Pomponi SA, Willoughby R, Wright AE, Pecorella C, Sennet SH, Lopez J, Samples G: In vitro production of marine-derived antitumor compounds; in Le Gal Y, Halvorson HO (eds): New Developments in Marine Biotechnology. New York, Plenum Press, 1998, p. 43.
86.
Guzman-Murillo MA, Ascencio F: Anti-adhesive activity of sulphated exopolysaccharides of microalgae on attachment of red sore disease-associated bacteria and Helicobacter pylori to tissue culture cells. Lett Appl Microbiol 2000;30:473–478.
87.
Gotonance R, Watanabe Y, Kamiya H, Ida H: Characterization of lectins from the skin mucus of the loach Misgurnus anguillicaudatus. Fish Sci 1995;61:137–140.
88.
McKenzie JD, Grigovala IV: The echinoderm surface and its role in preventing microfouling. Biofouling 1996;10:261–272.
89.
Fukuda M: Roles of mucin-type o- glycans in cell adhesion. Biochim Biophys Acta 2002;1573:394–405.
90.
Hicks SJ, Theodoropoulos G, Carrington SD, Corfield AP: The role of mucins in host-parasite interactions. 1. Protozoan parasites. Parasitol Today 2000;16:476–481.
91.
Theodoropoulos G, Hicks SJ, Corfield AP, Miller BG, Carrington SD: The role of mucins in host-parasite interactions. 2. Helminth parasites. Trends Parsitol 2001;17:130–136.
92.
Shi L, Ardehali R, Caldwell KD, Valint P: Mucin coating on polymeric material surfaces to suppress bacterial adhesion. Colloids Surf 2000;17:229–239.
93.
Smith CJ, Kaper JB, Mack DR: Intestinal mucin inhibits adhesion of human enteropathogenic Escherichia coli to Hep-2 cells. J Pediatr Gastroenterol Nutr 1995;21:269–276.
94.
Solzbacher D, Hanisch FG, van Alphen L, Gilsdorf JR, Schroten H: Mucin in middle ear effusions inhibits attachment of Haemophilus influenzae to mucosal epithelial cells. Eur Arch Otorhinolaryngol 2003;260:141–147.
95.
Aristoteli LP, Bojarski B, Willcox MDP: Isolation of conjunctival mucin and differential interaction with Pseudomonas aeruginosa strains of varied pathogenic potential. Exp Eye Res 2003;77:699–710.
96.
Ascencio F, Martinez-Arias W, Romero MJ, Wadstrom T: Analysis of the interaction of Aeromonas caviae, A. hydrophila and A. sobria with mucins. FEMS Immunol Med Microbiol 1998;20:219–229.
97.
Lillehoj EP, Hyun SW, Kim BT, Zhang XG, Lee DI, Rowland S, Kim KC: Muc1 mucins on the cell surface are adhesion sites for Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol 2001;280:L181–L187.
98.
Lillehoj EP, Kim BT, Kim KC: Identification of Pseudomonas aeruginosa flagellin as an adhesin for Muc1 mucin. Am J Physiol Lung Cell Mol Physiol 2002;282:L751–L756.
99.
Scharfman A, Arora SK, Delmotte P, Van Brussel E, Mazurier J, Ramphal R, Roussel P: Recognition of Lewis x derivatives present on mucins by flagellar components of Pseudomonas aeruginosa. Infect Immun 2001;69:5243–5248.
100.
Ouwehand AC, Kirjavainen PV, Gronlund MM, Isolauri E, Salminen SJ: Adhesion of probiotic micro-organisms to intestinal mucus. Int Dairy J 1999;9:623–630.
101.
Ouwehand AC, Tuomola EM, Tolkko S, Salminen S: Assessment of adhesion properties of novel probiotic strains to human intestinal mucus. Int J Food Microbiol 2001;64:119–126.
102.
Tuomola EM, Salminen SJ: Adhesion of some probiotic and dairy lactobacillus strains to Caco-2 cell cultures. Int J Food Microbiol 1998;41:45–51.
103.
Tuomola EM, Ouwehand AC, Salminen SJ: Chemical, physical and enzymatic pre-treatments of probiotic lactobacilli alter their adhesion to human intestinal mucus glycoproteins. Int J Food Microbiol 2000;60:75–81.
104.
Servin AL, Coconnier MH: Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens. Best Pract Res Clin Gastroenterol 2003;17:741–754.
105.
Kunz C, Rodriguez-Palmero M, Koletzko B, Jensen R: Nutritional and biochemical properties of human milk. 1. General aspects, proteins, and carbohydrates. Clin Perinatol 1999;26:307.
106.
Kunz C, Rudloff S, Baier W, Klein N, Strobel S: Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr 2000;20:699–722.
107.
Newburg DS: Bioactive components of human milk – Evolution, efficiency, and protection; in Newburg DS (ed): Bioactive Components of Human Milk. New York, Plenum Publishers, 2001, pp 3–10.
108.
Newburg DS: Oligosaccharides in human milk and bacterial colonization. J Pediatr Gastroenterol Nutr 2000;30:S8–S17.
109.
Martin-Sosa S, Martin MJ, Hueso P: The sialylated fraction of milk oligosaccharides is partially responsible for binding to enterotoxigenic and uropathogenic Escherichia coli human strains. J Nutr 2002;132:3067–3072.
110.
Nascimento de Araujo A, Giugliano LG: Human milk fractions inhibit the adherence of diffusely adherent Escherichia coli (DAEC) and enteroaggregative E. coli (EAEC) to HeLa cells. FEMS Microbiol Lett 2000;184:91–94.
111.
Cravioto A, Tello A, Villafan H, Ruiz J, Delvedovo S, Neeser JR: Inhibition of localized adhesion of enteropathogenic Escherichia coli to Hep-2 cells by immunoglobulin and oligosaccharide fractions of human colostrum and breast milk. J Infect Dis 1991;163:1247–1255.
112.
Schroten H, Hanisch FG, Plogmann R, Hacker J, Uhlenbruck G, Nobisbosch R, Wahn V: Inhibition of adhesion of S-fimbriated Escherichia coli to buccal epithelial cells by human milk fat globule membrane components: a novel aspect of the protective function of mucins in the nonimmunoglobulin fraction. Infect Immun 1992;60:2893–2899.
113.
Morrow AL, Ruiz-Palacios GM, Altaye M, Jiang X, Guerrero ML, Meinzen-Derr JK, Farkas T, Chaturvedi P, Pickering LK, Newburg DS: Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants. J Pediatr 2004;145:297–303.
114.
Mysore JV, Wigginton T, Simon PM, Zopf D, Heman-Ackah LM, Dubois A: Treatment of Helicobacter pylori infection in rhesus monkeys using a novel antiadhesion compound. Gastroenterology 1999;117:1316–1325.
115.
Yoon SS, Hennigan RF, Hilliard GM: Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis. Dev Cell 2002;3:593–603.
116.
Ramphal R, Arora SK: Recognition of mucin components by Pseudomonas aeruginosa. Glycoconj J 2001;18:709–713.
117.
Scharfman A, Kroczynski H, Carnoy C, VanBrussel E, Lamblin G, Ramphal R, Roussel P: Adhesion of Pseudomonas aeruginosa to respiratory mucins and expression of mucin-binding proteins are increased by limiting iron during growth. Infect Immun 1996;64:5417–5420.
118.
Bryan R, Feldman M, Speert D, Prince A: The use of carbohydrates to block the attachment of Pseudomonas aeruginosa to epithelial cells. Pediatr Res 1996;39:2290.
119.
DeBentzmann S, Roger P, Dupuit F, Bajolet-Laudinat O, Fuchey C, Plotkowski MC, Puchelle E: Asialo GM1 is a receptor for Pseudomonas aeruginosa adherence to regenerating respiratory epithelial cells. Infect Immun 1996;64:1582–1588.
120.
Feldman M, Bryan R, Rajan S, Scheffler L, Brunnert S, Tang H, Prince A: Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection. Infect Immun 1998;66:43–51.
121.
Rostand KS, Esko JD: Cholesterol and cholesterol esters: host receptors for Pseudomonas aeruginosa adherence. J Biol Chem 1993;268:24053–24059.
122.
Rebiere-Huet J, Di Martino P, Hulen C: Inhibition of Pseudomonas aeruginosa adhesion to fibronectin by PA-IL and monosaccharides: involvement of a lectin-like process. Can J Microbiol 2004;50:303–312.
123.
Rebiere-Huet J, Guerillon J, Pimenta AL, Di Martino P, Orange N, Hulen C: Porins of Pseudomonas fluorescens MFO as fibronectin-binding proteins. FEMS Microbiol Lett 2002;215:121–126.
124.
Plotkowski MC, Bernardo M, Meirelles MD, Tournier JM, Puchelle E: Pseudomonas aeruginosa binds to soluble cellular fibronectin. Curr Microbiol 1993;26:91–95.
125.
Roger P, Puchelle E, Bajolet-Laudinat O, Tournier JM, Debordeaux C, Plotkowski MC, Cohen JHM, Sheppard D, de Bentzmann S: Fibronectin and alpha 5 beta 1 integrin mediate binding of Pseudomonas aeruginosa to repairing airway epithelium. Eur Respir J 1999;13:1301–1309.
126.
Plotkowski MC, Tournier JM, Puchelle E: Pseudomonas aeruginosa strains possess specific adhesins for laminin. Infect Immun 1996;64:600–605.
127.
Doig P, Smith NR, Todd T, Irvin RT: Characterization of the binding of Pseudomonas aeruginosa alginate to human epithelial cells. Infect Immun 1987;55:1517–1522.
128.
Thomas R, Brooks T: Common oligosaccharide moieties inhibit the adherence of typical and atypical respiratory pathogens. J Med Microbiol 2004;53:833–840.
129.
Duran JA, Malvar A, Rodriguezares MT, Garciariestra C: Heparin inhibits Pseudomonas adherence to soft contact lenses. Eye 1993;7:152–154.
130.
Ramphal R, Carnoy C, Fievre S, Michalski JC, Houdret N, Lamblin G, Strecker G, Roussel P: Pseudomonas aeruginosa recognizes carbohydrate chains containing type 1 (Gal-beta-1–3GlcNAc) or type-2 (Gal-beta-1–4GlcNAc) disaccharide units. Infect Immun 1991;59:700–704.
131.
Debentzmann SG, Bajolet-Laudinat O, Dupuit F, Pierrot D, Fuchey C, Plotkowski MC, Puchelle E: Protection of human respiratory epithelium from Pseudomonas aeruginosa adherence by phosphatidylglycerol liposomes. Infect Immun 1994;62:704–708.
132.
Azghani AO, Williams I, Holiday DB, Johnson AR: A beta-linked mannan inhibits adherence of Pseudomonas aeruginosa to human lung epithelial cells. Glycobiology 1995;5:39–44.
133.
Rajan S, Cacalano G, Bryan R, Ratner AJ, Sontich CU, van Heerckeren A, Davis P, Prince A: Pseudomonas aeruginosa induction of apoptosis in respiratory epithelial cells: analysis of the effects of cystic fibrosis transmembrane conductance regulator dysfunction and bacterial virulence factors. Am J Respir Cell Mol Biol 2000;23:304–312.
134.
Barghouthi S, Guerdoud LM, Speert DP: Inhibition by dextran of Pseudomonas aeruginosa adherence to epithelial cells. Am J Respir Crit Care Med 1996;154:1788–1793.
135.
Bryan R, Feldman M, Jawetz SC, Rajan S, DiMango E, Tang HB, Scheffler L, Speert DP, Prince A: The effects of aerosolized dextran in a mouse model of Pseudomonas aeruginosa pulmonary infection. J Infect Dis 1999;179:1449–1458.
136.
Blaser MJ: Not all Helicobacter pylori strains are created equal: should all be eliminated? Lancet 1997;349:1020–1022.
137.
Karlsson KA: Meaning and therapeutic potential of microbial recognition of host glycoconjugates. Mol Microbiol 1998;29:1–11.
138.
Saitoh T, Natomi H, Zhao W, Okuzumi K, Sugano K, Iwamori M, Nagai Y: Identification of glycolipid receptors for Helicobacter pylori by TLC-immunostaining. FEBS Lett 1991;282:385–387.
139.
Chmiela M, Paziak-Domanska B, Rudnicka W, Wadstorm T: The role of heparan sulphate-binding activity of Helicobacter pylori bacteria in their adhesion to murine macrophages. APMIS 1995;103:469–474.
140.
Boren T, Falk P, Roth KA, Larson G, Normark S: Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993;262:1892–1895.
141.
Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, Incecik ET, Berg DE, Covacci A, Engstrand L, Boren T: Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998;279:373–377.
142.
Linden S, Boren T, Dubois A, Carlstedt I: Rhesus monkey gastric mucins: oligomeric structure, glycoforms and Helicobacter pylori binding. Biochem J 2004;379:765–775.
143.
Gold BD, Huesca M, Sherman PM, Lingwood CA: Helicobacter mustelae and Helicobacter pylori bind to common lipid receptors in vitro. Infect Immun 1993;61:2632–2638.
144.
Angstrom J, Teneberg S, Milh MA, Larsson T, Leonardsson I, Olsson BM, Halvarsson MO, Danielsson D, Naslund I, Ljungh A, Wadstrom T, Karlsson KA: The lactosylceramide binding specificity of Helicobacter pylori. Glycobiology 1998;8:297–309.
145.
Abul-Milh M, Foster DB, Lingwood CA: In vitro binding of Helicobacter pylori to monohexosylceramides. Glycoconj J 2001;18:253–260.
146.
Tang W, Seino K, Ito M, Konishi T, Senda H, Makuuchi M, Kojima N, Mizuochi T: Requirement of ceramide for adhesion of Helicobacter pylori to glycosphingolipids. FEBS Lett 2001;504:31–35.
147.
Lingwood CA, Huesca M, Kuksis A: The glycerolipid receptor for Helicobacter pylori (and exoenzyme-S) is phosphatidylethanolamine. Infect Immun 1992;60:2470–2474.
148.
Kojima N, Seino K, Sato Y, Mizuochi T: Carbohydrate carriers affect adhesion of H. pylori to immobilized Leb-oligosaccharide. FEBS Lett 2002;517:32–36.
149.
Gerhard M, Rad R, Martin S, Lehn N, Boren T, Classen M, Becker I, Schepp W, Roesch T, Prinz C: Adherence of Helicobacter pylori to Lewisb blood group antigens is associated with gastritis scores, ulcer disease and gastric adenocarcinoma. Gastroenterology 2000;118:3965.
150.
Linden S, Nordman H, Hedenbro J, Hurtig M, Boren T, Carlstedt I: Strain and blood group-dependent binding of Helicobacter pylori to human gastric MUC5AC glycoforms. Gastroenterology 2003;124:588.
151.
Hata Y, Murakami M, Okabe S: Glycoconjugates with NeuAc-NeuAc-Gal-Glc are more effective at preventing adhesion of Helicobacter pylori to gastric epithelial cells than glycoconjugates with NeuAc-Gal-Glc. J Physiol Pharmacol 2004;55:607–625.
152.
Lengsfeld C, Titgemeyer F, Faller G, Hensel A: Glycosylated compounds from okra inhibit adhesion of Helicobacter pylori to human gastric mucosa. J Agric Food Chem 2004;52:1495–1503.
153.
Burger O, Ofek I, Tabak M, Weiss EI, Sharon N, Neeman I: A high molecular mass constituent of cranberry juice inhibits Helicobacter pylori adhesion to human gastric mucus. FEMS Immunol Med Microbiol 2000;29:295–301.
154.
Parente F, Cucino C, Anderloni A, Grandinetti G, Porro GB: Treatment of Helicobacter pylori infection using a novel antiadhesion compound (3′sialyllactose sodium salt). A double blind, placebo-controlled clinical. Helicobacter 2003;8:252–256.
155.
Ukkonen P, Varis K, Jernfors M, Herva E, Jokinen J, Ruokokoski E, Zopf D, Kilpi T: Treatment of acute otitis media with an antiadhesive oligosaccharide: a randomised, double-blind, placebo-controlled trial. Lancet 2000;356:1398–1402.
156.
Tenke P, Riedl CR, Jones GL, Williams GJ, Stickler D, Nagy E: Bacterial biofilm formation on urologic devices and heparin coating as preventive strategy. Int J Antimicrob Agents 2004;23:S67–S74.
157.
Disney MD, Seeberger PH: The use of carbohydrate microarrays to study carbohydrate-cell interactions and to detect pathogens. Chem Biol 2004;11:1701–1707.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.